PALEO

Trial Description: 
A randomized phase II trial of Palbociclib in combination with Letrozole versus Letrozole Monotherapy for patients with Estrogen Receptor Positive advanced or recurrent Endometrial cancer.
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Endometrial
Trial Status: 
Recruiting
Contact person: